These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25962054)

  • 1. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway.
    Nandy SB; Arumugam A; Subramani R; Pedroza D; Hernandez K; Saltzstein E; Lakshmanaswamy R
    Oncotarget; 2015 Jul; 6(19):17366-78. PubMed ID: 25962054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
    Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
    Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
    Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
    Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-125a-5p promotes gastric cancer growth and invasion by regulating the Hippo pathway.
    Li R; Hu Z; Wang Z; Zhu T; Wang G; Gao B; Wang J; Deng X
    J Clin Lab Anal; 2021 Dec; 35(12):e24078. PubMed ID: 34708891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
    Xu X; Lv YG; Yan CY; Yi J; Ling R
    Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
    Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
    Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-377-3p regulates adipogenic differentiation of human bone marrow mesenchymal stem cells by regulating LIFR.
    Li X; Yang Y; Yan R; Xu X; Gao L; Mei J; Liu J; Wang X; Zhang J; Wu P; Li W; Zhao Z; Xiong J; Wang T
    Mol Cell Biochem; 2018 Dec; 449(1-2):295-303. PubMed ID: 29959592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
    Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
    Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis.
    Hsieh TH; Hsu CY; Tsai CF; Long CY; Chai CY; Hou MF; Lee JN; Wu DC; Wang SC; Tsai EM
    Oncotarget; 2015 Jan; 6(1):494-509. PubMed ID: 25504437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ.
    Yuan J; Xiao G; Peng G; Liu D; Wang Z; Liao Y; Liu Q; Wu M; Yuan X
    Biochem Biophys Res Commun; 2015 Feb; 457(2):171-6. PubMed ID: 25542152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling.
    El Helou R; Pinna G; Cabaud O; Wicinski J; Bhajun R; Guyon L; Rioualen C; Finetti P; Gros A; Mari B; Barbry P; Bertucci F; Bidaut G; Harel-Bellan A; Birnbaum D; Charafe-Jauffret E; Ginestier C
    Cell Rep; 2017 Feb; 18(9):2256-2268. PubMed ID: 28249169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
    Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippo pathway and breast cancer stem cells.
    Maugeri-Saccà M; De Maria R
    Crit Rev Oncol Hematol; 2016 Mar; 99():115-22. PubMed ID: 26725175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.
    Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD
    Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo pathway in mammary gland development and breast cancer.
    Shi P; Feng J; Chen C
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):53-9. PubMed ID: 25467757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-125a-5p expression is associated with the age of breast cancer patients.
    He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
    Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-125a-5p inhibits EMT of ovarian cancer cells by regulating TAZ/EGFR signaling pathway.
    Cao Y; Shen T; Zhang C; Zhang QH; Zhang ZQ
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8249-8256. PubMed ID: 31646555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.